Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 16.45B 2.43B 2.12B 1.96B 1.8B 3.4B 234B 3.48B 23.39B 9.2B 114B 9.11B 8.91B 394B P/E 2026 *
31.6x
P/E 2027 * -159x
Enterprise Value 16.45B 2.43B 2.12B 1.96B 1.8B 3.4B 234B 3.48B 23.39B 9.2B 114B 9.11B 8.91B 394B EV / Sales 2026 *
15.2x
EV / Sales 2027 * 13.1x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day-12.38%
1 week-7.75%
Current month-1.64%
1 month+9.72%
3 months+0.25%
6 months-0.78%
Current year+9.30%
1 week 35.84
Extreme 35.84
43.5
1 month 31.37
Extreme 31.37
44.8
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
81.48
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.5778
81.48
Manager TitleAgeSince
Chief Executive Officer 52 11/11/2015
Director of Finance/CFO 60 11/11/2015
Investor Relations Contact 38 31/12/2020
Director TitleAgeSince
Director/Board Member 70 01/07/2024
Chairman 52 11/11/2015
Director/Board Member 58 11/11/2015
Date Insider Type Main position Quantity % Market Cap.
05/01/26 Buy

Director

4,200 0.0010%
24/11/25 Buy

Director

7,000 0.0017%
01/09/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-12.38%-7.75%-45.36%+33.35% 2.43B
+0.60%+1.07%+14.76%+76.92% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
+1.80%+1.11%-2.12%+36.54% 11.9B
+1.33%+2.38%+19.40%+87.55% 11.85B
+0.93%+2.87%+34.92%+137.61% 9.31B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.75%-0.91%+17.45%+36.14% 6.91B
-.--%+0.14% - - 6.79B
-0.22%-3.15%+2.01%+200.91% 6.55B
Average -0.59%-1.23%+17.76%+79.29% 14.65B
Weighted average by Cap. +0.31%-0.78%+28.75%+85.63%

Financials

2026 *2027 *
Net sales 1.08B 159M 139M 128M 118M 223M 15.34B 228M 1.54B 604M 7.51B 598M 585M 25.87B 1.26B 186M 162M 150M 138M 260M 17.87B 266M 1.79B 704M 8.75B 697M 682M 30.13B
Net income 526M 77.6M 67.82M 62.58M 57.68M 109M 7.47B 111M 748M 294M 3.66B 291M 285M 12.6B -102M -15.05M -13.15M -12.14M -11.19M -21.08M -1.45B -21.55M -145M -57.05M -710M -56.51M -55.27M -2.44B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
17/07/26 CN¥36.67 -12.38% 21,128,034
16/07/26 CN¥41.85 +2.27% 23,962,701
15/07/26 CN¥40.92 +0.52% 27,558,495
14/07/26 CN¥40.71 +3.43% 19,727,349
13/07/26 CN¥39.36 -0.98% 18,154,135

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock